Change in curve changed the ratio of Cmax [Bioanalytics]

posted by Compliance – India, 2015-03-23 11:09 (3716 d 17:41 ago) – Posting: # 14596
Views: 12,398

Dear nobody,

To the answer your question:

Please note that i have taken CV of slope and intercept and it is within the 15%. However in entire method validation, only few of the QC's are getting fail to meet the acceptance which are also marginal.

Hence i could not doubt on the method. if there is any other point which i have to take care while qualifying method, then please share with me.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
22 visitors (0 registered, 22 guests [including 6 identified bots]).
Forum time: 05:50 CEST (Europe/Vienna)

Far better an approximate answer to the right question,
which is often vague, than an exact answer to the wrong question,
which can always be made precise.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5